Watts Ryan J.
President and CEO
Watts Ryan J. has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Watts Ryan J. is listed as President and CEO at Denali Therapeutics Inc. Inside the rolling window, Watts Ryan J. reported no open-market purchases and 1 open-market sale totaling $581K in DNLI.
Companies traded
Other insiders at DNLI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$581K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Watts Ryan J. made?
Watts Ryan J. has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Watts Ryan J. trade?
Watts Ryan J. has filed SEC Form 4 disclosures for 1 company, including DNLI.
When was Watts Ryan J.'s most recent SEC Form 4 filing?
Watts Ryan J.'s most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Watts Ryan J.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Watts Ryan J. is listed as President and CEO.
What is Watts Ryan J.'s total buy and sell value in the current window?
Inside the rolling retention window, Watts Ryan J. bought $0 and sold $581K based on SEC Form 4 filings.
What was Watts Ryan J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 35,198 DNLI shares on 2026-01-06, worth $581K, per SEC Form 4 filings.